The latest news from academia, regulators
research labs and other things of interest
Posted: September 19, 2008
Applied Nanoscience to Assist Emergency Filtration Products in Response to FDA Comments
(Nanowerk News) Applied Nanoscience Inc. (ANI) (PINKSHEETS: APNN), a nanotechnology-based filtration development company, today announced that it has committed to fully assist its future merger partner Emergency Filtration Products, Inc. (EFP), the developer of the NanoMask™, in the response to comments issued by the U.S. Food and Drug Administration (FDA) in relation to the 510(k) pre-market notification filed by EFP in connection with the NanoMask.
"We have been working diligently to help EFP prepare the response to FDA comments regarding the NanoMask pre-market notification, especially as it relates to the antimicrobial silver nanoparticle formulation which powers the NanoMask," said Thomas K. Allen, President and CEO, ANI. "Applied Nanoscience's management and scientific team plan to rapidly provide EFP with the necessary data to satisfy the FDA comments."
ANI is a marketer and developer of innovative, high performance nanotechnology-based filtration products (NanoFense™) to customers worldwide and is the owner of NEFT™ (Nanoparticle - Enhanced - Filtration - Technology), a broad platform with significant application potential. www.appliednanoscience.com
EFP is a filtration technology company that has a unique and highly efficient hydrophobic micro-particle silver nanoparticle coated medical air filter mask, the NanoMask, which is designed to reduce bioburden on contact for in diverse high challenge medical filtration venues. EFP has recently submitted a 510(k) medical device notification with the FDA for its surgical NanoMask.